Home Mf Research Sbi Healthcare Opportunities Fund Regular Plan Growth
SBI Mutual Fund

SBI Healthcare Opportunities Fund - Regular Plan - Growth

Others Solution Oriented Fund Of Funds
Fund House : SBI Mutual Fund
Overview
Returns
Portfolio
Analysis
Peer Comparison
Fund Family
Scheme Details
-
-
  • 1W
  • 2W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • SI
NAV (as on 2025-06-20)
417.66 0.46%
Fund Size (Total Assets)
-
Expense Ratio (Regular)
-%
Expense Ratio (Direct)
-%
SIP Returns
Period Invested for ₹1000 SIP Started on Investments Latest Value Abs. Returns
One Week 2025-06-13 ₹1,000.00 ₹979.19
-2.08 %
Two Week 2025-06-05 ₹1,000.00 ₹992.10
-0.79 %
One Month 2025-05-21 ₹1,000.00 ₹995.48
-0.45 %
Three Months 2025-03-24 ₹3,000.00 ₹2,985.32
-0.49 %
Six Months 2024-12-23 ₹6,000.00 ₹6,042.15
0.70 %
One Year 2024-06-20 ₹12,000.00 ₹12,478.73
3.99 %
Three Year 2022-06-21 ₹36,000.00 ₹52,342.12
45.39 %
Five Year 2020-06-22 ₹60,000.00 ₹102,676.49
71.13 %
Ten Year 2015-06-23 ₹120,000.00 ₹302,177.16
151.81 %
Since Inception 2004-12-31 ₹250,000.00 ₹1,720,564.09
588.23 %
Portfolio Summary
Company Name Sector Sector Type Nav(in %)
Sun Pharmaceutical Industries Ltd. Pharmaceuticals & Biotechnology Equity 12.73
Divi's Laboratories Ltd. Pharmaceuticals & Biotechnology Equity 7.39
Max Healthcare Institute Ltd. Healthcare Services Equity 6.40
Cipla Ltd. Pharmaceuticals & Biotechnology Equity 4.77
Lupin Ltd. Pharmaceuticals & Biotechnology Equity 4.46
Mankind Pharma Ltd. Pharmaceuticals & Biotechnology Equity 3.75
Krishna Institute of Medical Sciences Ltd. Healthcare Services Equity 3.34
Fortis Healthcare Ltd. Healthcare Services Equity 3.22
Ami Organics Ltd. Pharmaceuticals & Biotechnology Equity 3.19
Aster DM Healthcare Ltd. Healthcare Services Equity 3.18
Jupiter Life Line Hospitals Ltd. Healthcare Services Equity 3.18
Polymedicure Ltd. Healthcare Equipment & Supplies Equity 3.10
Abbott India Ltd. Pharmaceuticals & Biotechnology Equity 2.97
Aether Industries Ltd. Chemicals & Petrochemicals Equity 2.83
Alkem Laboratories Ltd. Pharmaceuticals & Biotechnology Equity 2.76
Torrent Pharmaceuticals Ltd. Pharmaceuticals & Biotechnology Equity 2.58
Aurobindo Pharma Ltd. Pharmaceuticals & Biotechnology Equity 2.49
Laurus Labs Ltd. Pharmaceuticals & Biotechnology Equity 2.48
Rainbow Children's Medicare Ltd. Healthcare Services Equity 2.43
Gland Pharma Ltd. Pharmaceuticals & Biotechnology Equity 2.33
Concord Biotech Ltd. Pharmaceuticals & Biotechnology Equity 1.90
Biocon Ltd. Pharmaceuticals & Biotechnology Equity 1.82
Vijaya Diagnostic Centre Ltd. Healthcare Services Equity 1.56
Cohance Lifesciences Ltd. Pharmaceuticals & Biotechnology Equity 1.53
Pfizer Ltd. Pharmaceuticals & Biotechnology Equity 1.52
Akums Drugs & Pharmaceuticals Ltd. Pharmaceuticals & Biotechnology Equity 1.24
Sanofi Consumer Healthcare India Ltd. Pharmaceuticals & Biotechnology Equity 1.07
Gufic Biosciences Ltd. Pharmaceuticals & Biotechnology Equity 1.06
Lonza Group Pharmaceuticals & Biotechnology Debt 4.81
182 DAY T-BILL 05.06.25 - Debt 0.08
TREPS - Debt 3.99
Net Receivable / Payable - - -0.16
Risk Ratios
Standard Deviation
14.57
Beta
0.88
Sharpe Ratio
0.75
Lock In Period
-
Residual Maturity
-
Standard Deviation:
Standard deviation numbers measure the variability or volatility of a fund's returns over a specific time period (often 3 years).
  • Low standard deviation = Stable, predictable returns → Suitable for conservative investors seeking stability.
  • High standard deviation = High volatility, more risk → Be cautious, suitable for risk-tolerant investors who can handle fluctuations.
Beta:
Beta measures a fund's volatility about the market or a benchmark. A lower beta means the fund's performance is less sensitive to market movements, making it more predictable compared to the market.
  • Low beta = Less sensitive to market changes → Great for investors with less market exposure.
  • High beta = More sensitive to market changes → Better for aggressive investors who seek higher returns but can handle market risks.
Sharpe Ratio:
The Sharpe Ratio measures how much return a fund has made compared to the risk it carries. A higher Sharpe ratio indicates better returns relative to the risk taken, meaning the fund delivers more efficiently.
  • A higher Sharpe ratio indicates better risk-adjusted returns → Look for funds with higher ratios for better return efficiency.
  • Use it to compare different funds' efficiency in generating returns relative to the risk taken.
Lock-In Period:

India's "lock-in period" in mutual funds encourages long-term investment, particularly in tax-saving schemes preventing redemption or selling of units.

Lock-in times for various investment types

  • Most ELSS mutual fund holders hold for 3 years.
  • Tax savings FDs lock in for 5 years.
  • The lock-in period for 8% Government of India bond investment is 6 years.
  • ULIPs must be locked in for 5 years.
  • The average hedge fund holding period is 30-90 days.
  • The average PPF investor holds onto their money for 15 years.
Residual Maturity:

Residual maturity is the remaining time until a security reaches its maturity date. It is an important factor for investors to consider when evaluating the risk associated with an investment.

There are two different types of residual maturity.

  • Short-term residual maturity: This occurs when a security has less than a year left on its maturity.
  • Long-term residual maturity: This occurs when a security has more than a year left on its remaining maturity.
Scheme Details
  • Fund manager(s) : Mr. Tanmaya Desai (Over 15 years), Mr. Pradeep Kesavan (Over 18 years),
  • Expense ration regular : -
  • Expense ration direct : -
  • Launch date : -
  • Benchmark : -
  • Min SIP amount : -
  • Max SIP amount : -
  • Min investment amount (one time- first time) : ₹500.00
  • Type : others
Exit load
For exit within 15 Days from the date of allotment - 0.50%; For exit after 15 Days from the date of allotment - Nil.

FAQs

Is a Mutual Fund with a Lower NAV Better?
What Are the Charges in Mutual Fund Investments?
What Are the Tax Benefits of Mutual Funds?
Is It a Good Time to Invest in Mutual Funds?
What Is the Difference Between Dividend and Growth Plans?
Should I Invest in Infrastructure Funds?
What Are Sector-Specific Funds/Schemes?
What Happens If I Miss an SIP Payment?
How Can I Compare Different Mutual Funds?